RxDoctor Payments DataLook up a doctor →

GEMTESA: payments to doctors

Payments that named GEMTESA as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$8.2M
Providers
44,887
Transactions
237,061
Average per transaction
$35

The per-transaction average — $35 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 44,887 providers the average total is $184, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Sumitomo Pharma America, Inc.$5,598,02967.9%
Urovant Sciences Inc$2,226,30227.0%
Sunovion Pharmaceuticals Inc.$424,6525.1%
← All drugs & devices